FIELD: medicine.
SUBSTANCE: for treatment patients with hypogonadism with obstructive sleep apnea syndrome before substitutive therapy with androgens CPAP- therapy is carried out. After that CPAP- therapy is realised simultaneously with therapy with testosterone medications until its normal level is recovered.
EFFECT: method allows to carry out substitutive therapy of hypogonadism in patients with syndrome of obstructive sleep apnea, who have relative contraindications to administering androgens.
3 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS SUFFERING FROM CHRONIC PROSTATITIS WITH PARTIAL ANDROGEN DEFICIENCY | 2013 |
|
RU2525182C1 |
| METHOD FOR PREDICTING THE MANIFESTATION OF HYPOGONADISM IN MEN | 2022 |
|
RU2786597C1 |
| METHOD FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES BY PRESCRIBING DIETARY SUPPLEMENTS FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES | 2012 |
|
RU2496491C1 |
| METHOD FOR CORRECTION OF ERECTILE DYSFUNCTION CAUSED BY HYPERESTRADIOLEMIA IN MEN | 2014 |
|
RU2582273C1 |
| METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
| METHOD OF TREATING PATIENTS WITH ERECTILE DYSFUNCTION | 2020 |
|
RU2730956C1 |
| METHOD FOR TREATING CHRONIC PROSTATITIS COMPLICATED BY ERECTILE DYSFUNCTION | 2021 |
|
RU2766735C1 |
| METHOD FOR DETERMINATION OF INDICATIONS FOR NASAL OBSTRUCTION RELEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2009 |
|
RU2402264C1 |
| METHOD OF TREATING ERECTILE DYSFUNCTION IN PATIENTS SUFFERING RADICAL PROSTATECTOMY OR BRACHYTHERAPY | 2020 |
|
RU2741204C2 |
| METHOD OF TREATING METABOLIC SYNDROM | 2010 |
|
RU2452523C1 |
